Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2021-02-21
Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of growth hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth Hormone Deficiency), TS (Turner Syndrome),CRF (Chronic Renal Failure), SGA (Small for Gestational Age), and ISS (Idiopathic Short Stature).
Conditions
- Growth Hormone Deficiency
- Turner Syndrome
- Chronic Renal Failure
- Small for Gestational Age
- Idiopathic Short Stature
Sponsors & Collaborators
-
LG Chem
lead INDUSTRY
Principal Investigators
-
HW Chae, M.D. · Kangnam severance hospital
-
KS Sim, M.D. · Kangdong KyungHee University hospital
-
IT Hwang, M.D. · Kangdong Sacred Heart Hospital
-
SC Chung, M.D. · Konkook University hospital
-
CW Ko, M.D. · Kyungpook National University Hospital
-
HS Kim, M.D. · Keimyung University hospital
-
YJ Lee, M.D. · Korea University
-
KH Lee, M.D. · Korea University Anam Hospital
-
JH Lee, M.D. · Kosin university hospital
-
JS Yu, M.D. · Dankook University
-
JH Yu, M.D. · Dong-A University Hospital
-
SY Lee, M.D. · SMG-SNU Boramae Medical Center
-
WY Chung, M.D. · Inje University
-
Yl Shin, M.D. · Buchun Soonchunhyang university hospital
-
CY Kim, M.D. · daejin medical center
-
DK Jin, M.D. · Samsung Medical Center
-
MJ Park, M.D. · Inje University
-
CH Shin, M.D. · Seoul National University Hospital
-
BK Suh, M.D. · Seoul St. Mary's Hospital
-
HW Yoo, M.D. · Asan Medical Center
-
MH Jung, M.D. · Yeouide St. Mary's hospital
-
SH Park, M.D. · St Vincent's Hospital
-
DH Kim, M.D. · Sowha children's hospital
-
DH Lee, M.D. · Seoul Soonchunhyang university hospital
-
HS Kim, M.D. · Sinchon severance hospital
-
JS Hwang, M.D. · Ajou University School of Medicine
-
SY Kim, M.D. · Pusan National University Yangsan Hospital
-
JD Kim, M.D. · Wonkwang university school of medicine & hospital
-
HS Han, M.D. · Chungbuk National University Hospital
-
KH Lee, M.D. · Wonkwang University Sanbon Medical Center
-
EK Yoo, M.D. · Bunsangcha hospital
-
BK Lim, M.D. · Wonju Christian Hospital
-
JH Kang, M.D. · Eulji University Hospital
-
JY Seo, M.D. · Eulji General Hospital
-
HS Kim, M.D. · ehwa university medical center
-
JE Lee, M.D. · Inha University Hospital
-
JH Kim, M.D. · Inje University
-
CJ Kim, M.D. · Chonnam National University Hospital
-
DY Lee, M.D. · Chonbuk National University Hospital
-
KS Shin, M.D. · Jeju National University Hospital
-
IT Hwang, M.D. · Hallym University Medical Center
-
SM Lee, M.D. · Hanyang University
-
KH Lee, M.D. · Korea University Guro Hospital
-
KS Jo, M.D. · Bucheon St. Mary's Hospital
-
SY Ahn, M.D. · KangWon National University Hospital
-
PS Oh, M.D. · Chuncheon Sacred Heart Hospital
-
S Yang, M.D. · Hallym University Kangnam Sacred Heart Hospital
-
EY Kim, M.D. · Chosun University Hospital
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2032-12-31
- Completion
- 2032-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
NCT03189160 ·Status: UNKNOWN ·Phase: PHASE2
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome
NCT06722079 ·Status: COMPLETED
-
A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
NCT00840944 ·Status: UNKNOWN ·Phase: PHASE4
-
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
NCT01604161 ·Status: COMPLETED
-
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
NCT00156143 ·Status: COMPLETED ·Phase: PHASE3
-
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
NCT07221851 ·Status: RECRUITING ·Phase: PHASE3
-
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 ·Status: COMPLETED
-
Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
NCT01859949 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial of YPEG-rhGH in Children With Short Stature
NCT05838885 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
NCT00097552 ·Status: COMPLETED
-
Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed
NCT06109935 ·Status: ENROLLING_BY_INVITATION
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT02976675 ·Status: UNKNOWN ·Phase: PHASE4
-
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
NCT06768411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
NCT00557336 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
NCT03255694 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency
NCT06024967 ·Status: UNKNOWN ·Phase: PHASE3
-
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
NCT00519844 ·Status: COMPLETED ·Phase: PHASE4
-
Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in Children
NCT03290235 ·Status: UNKNOWN ·Phase: PHASE4
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT03249480 ·Status: UNKNOWN ·Phase: PHASE4
-
Growth Response in Girls With Turner Syndrome
NCT01734486 ·Status: COMPLETED ·Phase: PHASE4
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT00458263 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
NCT01778023 ·Status: COMPLETED ·Phase: PHASE3